Archive · 5 Jan 2026
Hindustan Laboratories Files IPO Papers
Hindustan Laboratories, a company that makes generic medicines, has filed a DRHP with SEBI to go public.
They plan to sell 1,41,00,000 shares, with some new shares and some being sold by the promoter.
The money raised will be used for working capital and other company needs.
The shares will be listed on the BSE and NSE.
The company supplies medicines to government institutions across 27 states and union territories in India.
The company is based in Mumbai and produces a wide variety of medicines in different forms like tablets, capsules, and ointments.
Hindustan Laboratories has filed a DRHP with SEBI for its IPO, with a total issue size of 1,41,00,000 shares.
The IPO comprises a fresh issue of 50,00,000 shares and an offer for sale of 91,00,000 shares by promoter Rajesh Vasantray Doshi.
Proceeds from the fresh issue will be used for working capital and general corporate purposes.
The company is a pharmaceutical manufacturer supplying generic medicines to government institutions under a B2G framework.
Shares will be listed on the BSE and NSE, with Choice Capital Advisors as the book-running lead manager.
- Who
- Hindustan Laboratories, an Indian pharmaceutical company
- What
- Filed a DRHP with SEBI for its proposed IPO
- When
- Details not specified in the article
- Where
- India
- Why
- To raise funds for working capital and general corporate purposes
- Company
- Hindustan Laboratories
- Total Issue Size
- 1,41,00,000 shares
- Face Value per Share
- ₹10
- Fresh Issue
- 50,00,000 shares
- Offer for Sale (OFS)
- 91,00,000 shares
- Promoter Selling Shareholder
- Rajesh Vasantray Doshi
- Utilization of Proceeds
- Funding working capital and general corporate purposes
- Book-Running Lead Manager
- Choice Capital Advisors Private Limited
- Registrar
- MUFG Intime India Private Limited
- Listing Exchanges
- BSE and NSE
- Business Model
- Generic medicines supply under B2G framework
- Primary Markets
- 27 States and Union Territories
- Headquarters
- Mumbai
- Product Range
- Tablets, capsules, liquid orals, ointments, powders
Sources
Upcoming IPO: Hindustan Laboratories files DRHP with SEBI for an IPO; details here
Hindustan Laboratories files DRHP with SEBI to launch for IPO, check details
Drugmaker Hindustan Laboratories files IPO papers with Sebi to fund working capital
